APO Research
Talk to an analyst

APO RESEARCH · REPORT

E. coli Competent Cells

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global E. coli Competent Cells Market Analysis and Forecast 2026-2032

26 December 2025210 pages

Choose your research edition.

Industry ResearchE. coli Competent Cells Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal E. coli Competent Cells Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal E. coli Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal E. coli Competent Cells Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal E. coli Competent Cells Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global E. coli Competent Cells market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for E. coli Competent Cells is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for E. coli Competent Cells is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for E. coli Competent Cells is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for E. coli Competent Cells is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of E. coli Competent Cells include Addgene, Agilent, Beijing TransGen Biotech, Bioline, Bio-Rad, GCC Biotech, GenScript, IBA and LGC Biosearch Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for E. coli Competent Cells, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of E. coli Competent Cells, also provides the sales of main regions and countries. Of the upcoming market potential for E. coli Competent Cells, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the E. coli Competent Cells sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global E. coli Competent Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for E. coli Competent Cells sales, projected growth trends, production technology, application and end-user industry.

E. coli Competent Cells Segment by Company

Addgene

Agilent

Beijing TransGen Biotech

Bioline

Bio-Rad

GCC Biotech

GenScript

IBA

LGC Biosearch Technologies

New England Biolabs

New England Biolabs (NEB)

Promega Corporation

QIAGEN

Scarab Genomics

Takara Bio

Zymo Research

Beyotime

Maokangbio

Merck

Thermo Fisher Scientific

TIANGEN

NCM Biotech

Yeasen

ZOMANBIO

E. coli Competent Cells Segment by Type

Chemically Competent Cells

Electrocompetent Cells

E. coli Competent Cells Segment by Application

Cloning

Proteomics

Genomics

E. coli Competent Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E. coli Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of E. coli Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E. coli Competent Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of E. coli Competent Cells in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of E. coli Competent Cells manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, E. coli Competent Cells sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global E. coli Competent Cells Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Chemically Competent Cells Major Manufacturers Table 3. Electrocompetent Cells Major Manufacturers Table 4. Global E. coli Competent Cells Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cloning Major Manufacturers Table 6. Proteomics Major Manufacturers Table 7. Genomics Major Manufacturers Table 8. E. coli Competent Cells Industry Trends Table 9. E. coli Competent Cells Industry Drivers Table 10. E. coli Competent Cells Industry Opportunities and Challenges Table 11. E. coli Competent Cells Industry Restraints Table 12. Global E. coli Competent Cells Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global E. coli Competent Cells Revenue by Region (2021-2026) & (US$ Million) Table 14. Global E. coli Competent Cells Revenue by Region (2027-2032) & (US$ Million) Table 15. Global E. coli Competent Cells Revenue Market Share by Region (2021-2026) Table 16. Global E. coli Competent Cells Revenue Market Share by Region (2027-2032) Table 17. Global E. coli Competent Cells Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global E. coli Competent Cells Sales by Region (2021-2026) & (K Units) Table 19. Global E. coli Competent Cells Sales by Region (2027-2032) & (K Units) Table 20. Global E. coli Competent Cells Sales Market Share by Region (2021-2026) Table 21. Global E. coli Competent Cells Sales Market Share by Region (2027-2032) Table 22. Global E. coli Competent Cells Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global E. coli Competent Cells Revenue Market Share by Manufacturers (2021-2026) Table 24. Global E. coli Competent Cells Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global E. coli Competent Cells Sales Market Share by Manufacturers (2021-2026) Table 26. Global E. coli Competent Cells Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global E. coli Competent Cells Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global E. coli Competent Cells Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global E. coli Competent Cells Manufacturers, Product Type & Application Table 30. Global E. coli Competent Cells Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global E. coli Competent Cells by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global E. coli Competent Cells Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global E. coli Competent Cells Revenue by Type (2021-2026) & (US$ Million) Table 35. Global E. coli Competent Cells Revenue by Type (2027-2032) & (US$ Million) Table 36. Global E. coli Competent Cells Revenue Market Share by Type (2021-2026) Table 37. Global E. coli Competent Cells Revenue Market Share by Type (2027-2032) Table 38. Global E. coli Competent Cells Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global E. coli Competent Cells Sales by Type (2021-2026) & (K Units) Table 40. Global E. coli Competent Cells Sales by Type (2027-2032) & (K Units) Table 41. Global E. coli Competent Cells Sales Market Share by Type (2021-2026) Table 42. Global E. coli Competent Cells Sales Market Share by Type (2027-2032) Table 43. Global E. coli Competent Cells Price by Type (2021-2026) & (US$/Unit) Table 44. Global E. coli Competent Cells Price by Type (2027-2032) & (US$/Unit) Table 45. Global E. coli Competent Cells Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global E. coli Competent Cells Revenue by Application (2021-2026) & (US$ Million) Table 47. Global E. coli Competent Cells Revenue by Application (2027-2032) & (US$ Million) Table 48. Global E. coli Competent Cells Revenue Market Share by Application (2021-2026) Table 49. Global E. coli Competent Cells Revenue Market Share by Application (2027-2032) Table 50. Global E. coli Competent Cells Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global E. coli Competent Cells Sales by Application (2021-2026) & (K Units) Table 52. Global E. coli Competent Cells Sales by Application (2027-2032) & (K Units) Table 53. Global E. coli Competent Cells Sales Market Share by Application (2021-2026) Table 54. Global E. coli Competent Cells Sales Market Share by Application (2027-2032) Table 55. Global E. coli Competent Cells Price by Application (2021-2026) & (US$/Unit) Table 56. Global E. coli Competent Cells Price by Application (2027-2032) & (US$/Unit) Table 57. Addgene Company Information Table 58. Addgene Business Overview Table 59. Addgene E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Addgene E. coli Competent Cells Product Portfolio Table 61. Addgene Recent Development Table 62. Agilent Company Information Table 63. Agilent Business Overview Table 64. Agilent E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Agilent E. coli Competent Cells Product Portfolio Table 66. Agilent Recent Development Table 67. Beijing TransGen Biotech Company Information Table 68. Beijing TransGen Biotech Business Overview Table 69. Beijing TransGen Biotech E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Beijing TransGen Biotech E. coli Competent Cells Product Portfolio Table 71. Beijing TransGen Biotech Recent Development Table 72. Bioline Company Information Table 73. Bioline Business Overview Table 74. Bioline E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bioline E. coli Competent Cells Product Portfolio Table 76. Bioline Recent Development Table 77. Bio-Rad Company Information Table 78. Bio-Rad Business Overview Table 79. Bio-Rad E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bio-Rad E. coli Competent Cells Product Portfolio Table 81. Bio-Rad Recent Development Table 82. GCC Biotech Company Information Table 83. GCC Biotech Business Overview Table 84. GCC Biotech E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GCC Biotech E. coli Competent Cells Product Portfolio Table 86. GCC Biotech Recent Development Table 87. GenScript Company Information Table 88. GenScript Business Overview Table 89. GenScript E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. GenScript E. coli Competent Cells Product Portfolio Table 91. GenScript Recent Development Table 92. IBA Company Information Table 93. IBA Business Overview Table 94. IBA E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. IBA E. coli Competent Cells Product Portfolio Table 96. IBA Recent Development Table 97. LGC Biosearch Technologies Company Information Table 98. LGC Biosearch Technologies Business Overview Table 99. LGC Biosearch Technologies E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. LGC Biosearch Technologies E. coli Competent Cells Product Portfolio Table 101. LGC Biosearch Technologies Recent Development Table 102. New England Biolabs Company Information Table 103. New England Biolabs Business Overview Table 104. New England Biolabs E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. New England Biolabs E. coli Competent Cells Product Portfolio Table 106. New England Biolabs Recent Development Table 107. New England Biolabs (NEB) Company Information Table 108. New England Biolabs (NEB) Business Overview Table 109. New England Biolabs (NEB) E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. New England Biolabs (NEB) E. coli Competent Cells Product Portfolio Table 111. New England Biolabs (NEB) Recent Development Table 112. Promega Corporation Company Information Table 113. Promega Corporation Business Overview Table 114. Promega Corporation E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Promega Corporation E. coli Competent Cells Product Portfolio Table 116. Promega Corporation Recent Development Table 117. QIAGEN Company Information Table 118. QIAGEN Business Overview Table 119. QIAGEN E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. QIAGEN E. coli Competent Cells Product Portfolio Table 121. QIAGEN Recent Development Table 122. Scarab Genomics Company Information Table 123. Scarab Genomics Business Overview Table 124. Scarab Genomics E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Scarab Genomics E. coli Competent Cells Product Portfolio Table 126. Scarab Genomics Recent Development Table 127. Takara Bio Company Information Table 128. Takara Bio Business Overview Table 129. Takara Bio E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Takara Bio E. coli Competent Cells Product Portfolio Table 131. Takara Bio Recent Development Table 132. Zymo Research Company Information Table 133. Zymo Research Business Overview Table 134. Zymo Research E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Zymo Research E. coli Competent Cells Product Portfolio Table 136. Zymo Research Recent Development Table 137. Beyotime Company Information Table 138. Beyotime Business Overview Table 139. Beyotime E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Beyotime E. coli Competent Cells Product Portfolio Table 141. Beyotime Recent Development Table 142. Maokangbio Company Information Table 143. Maokangbio Business Overview Table 144. Maokangbio E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Maokangbio E. coli Competent Cells Product Portfolio Table 146. Maokangbio Recent Development Table 147. Merck Company Information Table 148. Merck Business Overview Table 149. Merck E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Merck E. coli Competent Cells Product Portfolio Table 151. Merck Recent Development Table 152. Thermo Fisher Scientific Company Information Table 153. Thermo Fisher Scientific Business Overview Table 154. Thermo Fisher Scientific E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Thermo Fisher Scientific E. coli Competent Cells Product Portfolio Table 156. Thermo Fisher Scientific Recent Development Table 157. TIANGEN Company Information Table 158. TIANGEN Business Overview Table 159. TIANGEN E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. TIANGEN E. coli Competent Cells Product Portfolio Table 161. TIANGEN Recent Development Table 162. NCM Biotech Company Information Table 163. NCM Biotech Business Overview Table 164. NCM Biotech E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. NCM Biotech E. coli Competent Cells Product Portfolio Table 166. NCM Biotech Recent Development Table 167. Yeasen Company Information Table 168. Yeasen Business Overview Table 169. Yeasen E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Yeasen E. coli Competent Cells Product Portfolio Table 171. Yeasen Recent Development Table 172. ZOMANBIO Company Information Table 173. ZOMANBIO Business Overview Table 174. ZOMANBIO E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. ZOMANBIO E. coli Competent Cells Product Portfolio Table 176. ZOMANBIO Recent Development Table 177. North America E. coli Competent Cells Revenue by Type (2021-2026) & (US$ Million) Table 178. North America E. coli Competent Cells Revenue by Type (2027-2032) & (US$ Million) Table 179. North America E. coli Competent Cells Sales by Type (2021-2026) & (K Units) Table 180. North America E. coli Competent Cells Sales by Type (2027-2032) & (K Units) Table 181. North America E. coli Competent Cells Sales Price by Type (2021-2026) & (US$/Unit) Table 182. North America E. coli Competent Cells Sales Price by Type (2027-2032) & (US$/Unit) Table 183. North America E. coli Competent Cells Revenue by Application (2021-2026) & (US$ Million) Table 184. North America E. coli Competent Cells Revenue by Application (2027-2032) & (US$ Million) Table 185. North America E. coli Competent Cells Sales by Application (2021-2026) & (K Units) Table 186. North America E. coli Competent Cells Sales by Application (2027-2032) & (K Units) Table 187. North America E. coli Competent Cells Sales Price by Application (2021-2026) & (US$/Unit) Table 188. North America E. coli Competent Cells Sales Price by Application (2027-2032) & (US$/Unit) Table 189. North America E. coli Competent Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. North America E. coli Competent Cells Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. North America E. coli Competent Cells Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. North America E. coli Competent Cells Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. North America E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 194. North America E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 195. North America E. coli Competent Cells Sales Price by Country (2021-2026) & (US$/Unit) Table 196. North America E. coli Competent Cells Sales Price by Country (2027-2032) & (US$/Unit) Table 197. United States E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 198. Canada E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 199. Mexico E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 200. Europe E. coli Competent Cells Revenue by Type (2021-2026) & (US$ Million) Table 201. Europe E. coli Competent Cells Revenue by Type (2027-2032) & (US$ Million) Table 202. Europe E. coli Competent Cells Sales by Type (2021-2026) & (K Units) Table 203. Europe E. coli Competent Cells Sales by Type (2027-2032) & (K Units) Table 204. Europe E. coli Competent Cells Sales Price by Type (2021-2026) & (US$/Unit) Table 205. Europe E. coli Competent Cells Sales Price by Type (2027-2032) & (US$/Unit) Table 206. Europe E. coli Competent Cells Revenue by Application (2021-2026) & (US$ Million) Table 207. Europe E. coli Competent Cells Revenue by Application (2027-2032) & (US$ Million) Table 208. Europe E. coli Competent Cells Sales by Application (2021-2026) & (K Units) Table 209. Europe E. coli Competent Cells Sales by Application (2027-2032) & (K Units) Table 210. Europe E. coli Competent Cells Sales Price by Application (2021-2026) & (US$/Unit) Table 211. Europe E. coli Competent Cells Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Europe E. coli Competent Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Europe E. coli Competent Cells Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Europe E. coli Competent Cells Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Europe E. coli Competent Cells Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 216. Europe E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 217. Europe E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 218. Europe E. coli Competent Cells Sales Price by Country (2021-2026) & (US$/Unit) Table 219. Europe E. coli Competent Cells Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Germany E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 221. France E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 222. U.K. E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 223. Italy E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 224. Russia E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 225. Spain E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 226. Netherlands E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 227. Switzerland E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 228. Sweden E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 229. Poland E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 230. China E. coli Competent Cells Revenue by Type (2021-2026) & (US$ Million) Table 231. China E. coli Competent Cells Revenue by Type (2027-2032) & (US$ Million) Table 232. China E. coli Competent Cells Sales by Type (2021-2026) & (K Units) Table 233. China E. coli Competent Cells Sales by Type (2027-2032) & (K Units) Table 234. China E. coli Competent Cells Sales Price by Type (2021-2026) & (US$/Unit) Table 235. China E. coli Competent Cells Sales Price by Type (2027-2032) & (US$/Unit) Table 236. China E. coli Competent Cells Revenue by Application (2021-2026) & (US$ Million) Table 237. China E. coli Competent Cells Revenue by Application (2027-2032) & (US$ Million) Table 238. China E. coli Competent Cells Sales by Application (2021-2026) & (K Units) Table 239. China E. coli Competent Cells Sales by Application (2027-2032) & (K Units) Table 240. China E. coli Competent Cells Sales Price by Application (2021-2026) & (US$/Unit) Table 241. China E. coli Competent Cells Sales Price by Application (2027-2032) & (US$/Unit) Table 242. Asia E. coli Competent Cells Revenue by Type (2021-2026) & (US$ Million) Table 243. Asia E. coli Competent Cells Revenue by Type (2027-2032) & (US$ Million) Table 244. Asia E. coli Competent Cells Sales by Type (2021-2026) & (K Units) Table 245. Asia E. coli Competent Cells Sales by Type (2027-2032) & (K Units) Table 246. Asia E. coli Competent Cells Sales Price by Type (2021-2026) & (US$/Unit) Table 247. Asia E. coli Competent Cells Sales Price by Type (2027-2032) & (US$/Unit) Table 248. Asia E. coli Competent Cells Revenue by Application (2021-2026) & (US$ Million) Table 249. Asia E. coli Competent Cells Revenue by Application (2027-2032) & (US$ Million) Table 250. Asia E. coli Competent Cells Sales by Application (2021-2026) & (K Units) Table 251. Asia E. coli Competent Cells Sales by Application (2027-2032) & (K Units) Table 252. Asia E. coli Competent Cells Sales Price by Application (2021-2026) & (US$/Unit) Table 253. Asia E. coli Competent Cells Sales Price by Application (2027-2032) & (US$/Unit) Table 254. Asia E. coli Competent Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. Asia E. coli Competent Cells Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. Asia E. coli Competent Cells Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. Asia E. coli Competent Cells Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 258. Asia E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 259. Asia E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 260. Asia E. coli Competent Cells Sales Price by Country (2021-2026) & (US$/Unit) Table 261. Asia E. coli Competent Cells Sales Price by Country (2027-2032) & (US$/Unit) Table 262. Japan E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 263. South Korea E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 264. India E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 265. Australia E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 266. Taiwan E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 267. Southeast Asia E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 268. SAMEA E. coli Competent Cells Revenue by Type (2021-2026) & (US$ Million) Table 269. SAMEA E. coli Competent Cells Revenue by Type (2027-2032) & (US$ Million) Table 270. SAMEA E. coli Competent Cells Sales by Type (2021-2026) & (K Units) Table 271. SAMEA E. coli Competent Cells Sales by Type (2027-2032) & (K Units) Table 272. SAMEA E. coli Competent Cells Sales Price by Type (2021-2026) & (US$/Unit) Table 273. SAMEA E. coli Competent Cells Sales Price by Type (2027-2032) & (US$/Unit) Table 274. SAMEA E. coli Competent Cells Revenue by Application (2021-2026) & (US$ Million) Table 275. SAMEA E. coli Competent Cells Revenue by Application (2027-2032) & (US$ Million) Table 276. SAMEA E. coli Competent Cells Sales by Application (2021-2026) & (K Units) Table 277. SAMEA E. coli Competent Cells Sales by Application (2027-2032) & (K Units) Table 278. SAMEA E. coli Competent Cells Sales Price by Application (2021-2026) & (US$/Unit) Table 279. SAMEA E. coli Competent Cells Sales Price by Application (2027-2032) & (US$/Unit) Table 280. SAMEA E. coli Competent Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 281. SAMEA E. coli Competent Cells Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 282. SAMEA E. coli Competent Cells Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 283. SAMEA E. coli Competent Cells Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 284. SAMEA E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 285. SAMEA E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 286. SAMEA E. coli Competent Cells Sales Price by Country (2021-2026) & (US$/Unit) Table 287. SAMEA E. coli Competent Cells Sales Price by Country (2027-2032) & (US$/Unit) Table 288. Brazil E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 289. Argentina E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 290. Chile E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 291. Colombia E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 292. Peru E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 293. Saudi Arabia E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 294. Israel E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 295. UAE E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 296. Turkey E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 297. Iran E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 298. Egypt E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Table 299. Key Raw Materials Table 300. Raw Materials Key Suppliers Table 301. E. coli Competent Cells Distributors List Table 302. E. coli Competent Cells Customers List Table 303. Research Programs/Design for This Report Table 304. Authors List of This Report Table 305. Secondary Sources Table 306. Primary Sources List of Figures Figure 1. E. coli Competent Cells Image Figure 2. Global E. coli Competent Cells Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global E. coli Competent Cells Market Size Share 2021 VS 2025 VS 2032 Figure 4. Chemically Competent Cells Image Figure 5. Electrocompetent Cells Image Figure 6. Global E. coli Competent Cells Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global E. coli Competent Cells Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cloning Image Figure 9. Proteomics Image Figure 10. Genomics Image Figure 11. Global E. coli Competent Cells Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global E. coli Competent Cells Revenue (2021-2032) & (US$ Million) Figure 13. Global E. coli Competent Cells Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global E. coli Competent Cells Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global E. coli Competent Cells Revenue Market Share by Region (2021-2032) Figure 16. Global E. coli Competent Cells Sales (2021-2032) & (K Units) Figure 17. Global E. coli Competent Cells Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global E. coli Competent Cells Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico E. coli Competent Cells Sales YoY (2021-2032) & (K Units) Figure 20. Europe E. coli Competent Cells Sales YoY (2021-2032) & (K Units) Figure 21. China E. coli Competent Cells Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) E. coli Competent Cells Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa E. coli Competent Cells Sales YoY (2021-2032) & (K Units) Figure 24. Global E. coli Competent Cells Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global E. coli Competent Cells Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global E. coli Competent Cells Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global E. coli Competent Cells Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global E. coli Competent Cells Revenue Market Share by Type (2021-2032) Figure 30. Global E. coli Competent Cells Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global E. coli Competent Cells Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global E. coli Competent Cells Sales Market Share by Type (2021-2032) Figure 33. Global E. coli Competent Cells Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global E. coli Competent Cells Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global E. coli Competent Cells Revenue Market Share by Application (2021-2032) Figure 36. Global E. coli Competent Cells Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global E. coli Competent Cells Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global E. coli Competent Cells Sales Market Share by Application (2021-2032) Figure 39. North America E. coli Competent Cells Revenue Share by Type (2021-2032) Figure 40. North America E. coli Competent Cells Sales Share by Type (2021-2032) Figure 41. North America E. coli Competent Cells Revenue Share by Application (2021-2032) Figure 42. North America E. coli Competent Cells Sales Share by Application (2021-2032) Figure 43. North America E. coli Competent Cells Revenue Share by Country (2021-2032) Figure 44. North America E. coli Competent Cells Sales Share by Country (2021-2032) Figure 45. Europe E. coli Competent Cells Revenue Share by Type (2021-2032) Figure 46. Europe E. coli Competent Cells Sales Share by Type (2021-2032) Figure 47. Europe E. coli Competent Cells Revenue Share by Application (2021-2032) Figure 48. Europe E. coli Competent Cells Sales Share by Application (2021-2032) Figure 49. Europe E. coli Competent Cells Revenue Share by Country (2021-2032) Figure 50. Europe E. coli Competent Cells Sales Share by Country (2021-2032) Figure 51. China E. coli Competent Cells Revenue Share by Type (2021-2032) Figure 52. China E. coli Competent Cells Sales Share by Type (2021-2032) Figure 53. China E. coli Competent Cells Revenue Share by Application (2021-2032) Figure 54. China E. coli Competent Cells Sales Share by Application (2021-2032) Figure 55. Asia E. coli Competent Cells Revenue Share by Type (2021-2032) Figure 56. Asia E. coli Competent Cells Sales Share by Type (2021-2032) Figure 57. Asia E. coli Competent Cells Revenue Share by Application (2021-2032) Figure 58. Asia E. coli Competent Cells Sales Share by Application (2021-2032) Figure 59. Asia E. coli Competent Cells Revenue Share by Country (2021-2032) Figure 60. Asia E. coli Competent Cells Sales Share by Country (2021-2032) Figure 61. SAMEA E. coli Competent Cells Revenue Share by Type (2021-2032) Figure 62. SAMEA E. coli Competent Cells Sales Share by Type (2021-2032) Figure 63. SAMEA E. coli Competent Cells Revenue Share by Application (2021-2032) Figure 64. SAMEA E. coli Competent Cells Sales Share by Application (2021-2032) Figure 65. SAMEA E. coli Competent Cells Revenue Share by Country (2021-2032) Figure 66. SAMEA E. coli Competent Cells Sales Share by Country (2021-2032) Figure 67. E. coli Competent Cells Value Chain Figure 68. Manufacturing Cost Structure Figure 69. E. coli Competent Cells Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Chemically Competent Cells
  • Electrocompetent Cells
Applications
  • Cloning
  • Proteomics
  • Genomics
Companies covered
  • Addgene
  • Agilent
  • Beijing TransGen Biotech
  • Bioline
  • Bio-Rad
  • GCC Biotech
  • GenScript
  • IBA
  • LGC Biosearch Technologies
  • New England Biolabs
  • New England Biolabs (NEB)
  • Promega Corporation
  • QIAGEN
  • Scarab Genomics
  • Takara Bio
  • Zymo Research
  • Beyotime
  • Maokangbio
  • Merck
  • Thermo Fisher Scientific
  • TIANGEN
  • NCM Biotech
  • Yeasen
  • ZOMANBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 E. coli Competent Cells Market by Type
  3. 1.2.1 Global E. coli Competent Cells Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Chemically Competent Cells
  5. 1.2.3 Electrocompetent Cells
  6. 1.3 E. coli Competent Cells Market by Application
  7. 1.3.1 Global E. coli Competent Cells Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cloning
  9. 1.3.3 Proteomics
  10. 1.3.4 Genomics
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 E. coli Competent Cells Market Dynamics
  1. 2.1 E. coli Competent Cells Industry Trends
  2. 2.2 E. coli Competent Cells Industry Drivers
  3. 2.3 E. coli Competent Cells Industry Opportunities and Challenges
  4. 2.4 E. coli Competent Cells Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global E. coli Competent Cells Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global E. coli Competent Cells Revenue by Region
  3. 3.2.1 Global E. coli Competent Cells Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global E. coli Competent Cells Revenue by Region (2021-2026)
  5. 3.2.3 Global E. coli Competent Cells Revenue by Region (2027-2032)
  6. 3.2.4 Global E. coli Competent Cells Revenue Market Share by Region (2021-2032)
  7. 3.3 Global E. coli Competent Cells Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global E. coli Competent Cells Sales by Region
  9. 3.4.1 Global E. coli Competent Cells Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global E. coli Competent Cells Sales by Region (2021-2026)
  11. 3.4.3 Global E. coli Competent Cells Sales by Region (2027-2032)
  12. 3.4.4 Global E. coli Competent Cells Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global E. coli Competent Cells Revenue by Manufacturers
  2. 4.1.1 Global E. coli Competent Cells Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global E. coli Competent Cells Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global E. coli Competent Cells Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global E. coli Competent Cells Sales by Manufacturers
  6. 4.2.1 Global E. coli Competent Cells Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global E. coli Competent Cells Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global E. coli Competent Cells Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global E. coli Competent Cells Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global E. coli Competent Cells Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global E. coli Competent Cells Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global E. coli Competent Cells Manufacturers, Product Type & Application
  13. 4.7 Global E. coli Competent Cells Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global E. coli Competent Cells Market CR5 and HHI
  16. 4.8.2 2025 E. coli Competent Cells Tier 1, Tier 2, and Tier 3
5 E. coli Competent Cells Market by Type
  1. 5.1 Global E. coli Competent Cells Revenue by Type
  2. 5.1.1 Global E. coli Competent Cells Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global E. coli Competent Cells Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global E. coli Competent Cells Revenue Market Share by Type (2021-2032)
  5. 5.2 Global E. coli Competent Cells Sales by Type
  6. 5.2.1 Global E. coli Competent Cells Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global E. coli Competent Cells Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global E. coli Competent Cells Sales Market Share by Type (2021-2032)
  9. 5.3 Global E. coli Competent Cells Price by Type
6 E. coli Competent Cells Market by Application
  1. 6.1 Global E. coli Competent Cells Revenue by Application
  2. 6.1.1 Global E. coli Competent Cells Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global E. coli Competent Cells Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global E. coli Competent Cells Revenue Market Share by Application (2021-2032)
  5. 6.2 Global E. coli Competent Cells Sales by Application
  6. 6.2.1 Global E. coli Competent Cells Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global E. coli Competent Cells Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global E. coli Competent Cells Sales Market Share by Application (2021-2032)
  9. 6.3 Global E. coli Competent Cells Price by Application
7 Company Profiles
  1. 7.1 Addgene
  2. 7.1.1 Addgene Company Information
  3. 7.1.2 Addgene Business Overview
  4. 7.1.3 Addgene E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Addgene E. coli Competent Cells Product Portfolio
  6. 7.1.5 Addgene Recent Developments
  7. 7.2 Agilent
  8. 7.2.1 Agilent Company Information
  9. 7.2.2 Agilent Business Overview
  10. 7.2.3 Agilent E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Agilent E. coli Competent Cells Product Portfolio
  12. 7.2.5 Agilent Recent Developments
  13. 7.3 Beijing TransGen Biotech
  14. 7.3.1 Beijing TransGen Biotech Company Information
  15. 7.3.2 Beijing TransGen Biotech Business Overview
  16. 7.3.3 Beijing TransGen Biotech E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Beijing TransGen Biotech E. coli Competent Cells Product Portfolio
  18. 7.3.5 Beijing TransGen Biotech Recent Developments
  19. 7.4 Bioline
  20. 7.4.1 Bioline Company Information
  21. 7.4.2 Bioline Business Overview
  22. 7.4.3 Bioline E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bioline E. coli Competent Cells Product Portfolio
  24. 7.4.5 Bioline Recent Developments
  25. 7.5 Bio-Rad
  26. 7.5.1 Bio-Rad Company Information
  27. 7.5.2 Bio-Rad Business Overview
  28. 7.5.3 Bio-Rad E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bio-Rad E. coli Competent Cells Product Portfolio
  30. 7.5.5 Bio-Rad Recent Developments
  31. 7.6 GCC Biotech
  32. 7.6.1 GCC Biotech Company Information
  33. 7.6.2 GCC Biotech Business Overview
  34. 7.6.3 GCC Biotech E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GCC Biotech E. coli Competent Cells Product Portfolio
  36. 7.6.5 GCC Biotech Recent Developments
  37. 7.7 GenScript
  38. 7.7.1 GenScript Company Information
  39. 7.7.2 GenScript Business Overview
  40. 7.7.3 GenScript E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GenScript E. coli Competent Cells Product Portfolio
  42. 7.7.5 GenScript Recent Developments
  43. 7.8 IBA
  44. 7.8.1 IBA Company Information
  45. 7.8.2 IBA Business Overview
  46. 7.8.3 IBA E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 IBA E. coli Competent Cells Product Portfolio
  48. 7.8.5 IBA Recent Developments
  49. 7.9 LGC Biosearch Technologies
  50. 7.9.1 LGC Biosearch Technologies Company Information
  51. 7.9.2 LGC Biosearch Technologies Business Overview
  52. 7.9.3 LGC Biosearch Technologies E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 LGC Biosearch Technologies E. coli Competent Cells Product Portfolio
  54. 7.9.5 LGC Biosearch Technologies Recent Developments
  55. 7.10 New England Biolabs
  56. 7.10.1 New England Biolabs Company Information
  57. 7.10.2 New England Biolabs Business Overview
  58. 7.10.3 New England Biolabs E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 New England Biolabs E. coli Competent Cells Product Portfolio
  60. 7.10.5 New England Biolabs Recent Developments
  61. 7.11 New England Biolabs (NEB)
  62. 7.11.1 New England Biolabs (NEB) Company Information
  63. 7.11.2 New England Biolabs (NEB) Business Overview
  64. 7.11.3 New England Biolabs (NEB) E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 New England Biolabs (NEB) E. coli Competent Cells Product Portfolio
  66. 7.11.5 New England Biolabs (NEB) Recent Developments
  67. 7.12 Promega Corporation
  68. 7.12.1 Promega Corporation Company Information
  69. 7.12.2 Promega Corporation Business Overview
  70. 7.12.3 Promega Corporation E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Promega Corporation E. coli Competent Cells Product Portfolio
  72. 7.12.5 Promega Corporation Recent Developments
  73. 7.13 QIAGEN
  74. 7.13.1 QIAGEN Company Information
  75. 7.13.2 QIAGEN Business Overview
  76. 7.13.3 QIAGEN E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 QIAGEN E. coli Competent Cells Product Portfolio
  78. 7.13.5 QIAGEN Recent Developments
  79. 7.14 Scarab Genomics
  80. 7.14.1 Scarab Genomics Company Information
  81. 7.14.2 Scarab Genomics Business Overview
  82. 7.14.3 Scarab Genomics E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Scarab Genomics E. coli Competent Cells Product Portfolio
  84. 7.14.5 Scarab Genomics Recent Developments
  85. 7.15 Takara Bio
  86. 7.15.1 Takara Bio Company Information
  87. 7.15.2 Takara Bio Business Overview
  88. 7.15.3 Takara Bio E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Takara Bio E. coli Competent Cells Product Portfolio
  90. 7.15.5 Takara Bio Recent Developments
  91. 7.16 Zymo Research
  92. 7.16.1 Zymo Research Company Information
  93. 7.16.2 Zymo Research Business Overview
  94. 7.16.3 Zymo Research E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Zymo Research E. coli Competent Cells Product Portfolio
  96. 7.16.5 Zymo Research Recent Developments
  97. 7.17 Beyotime
  98. 7.17.1 Beyotime Company Information
  99. 7.17.2 Beyotime Business Overview
  100. 7.17.3 Beyotime E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Beyotime E. coli Competent Cells Product Portfolio
  102. 7.17.5 Beyotime Recent Developments
  103. 7.18 Maokangbio
  104. 7.18.1 Maokangbio Company Information
  105. 7.18.2 Maokangbio Business Overview
  106. 7.18.3 Maokangbio E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Maokangbio E. coli Competent Cells Product Portfolio
  108. 7.18.5 Maokangbio Recent Developments
  109. 7.19 Merck
  110. 7.19.1 Merck Company Information
  111. 7.19.2 Merck Business Overview
  112. 7.19.3 Merck E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Merck E. coli Competent Cells Product Portfolio
  114. 7.19.5 Merck Recent Developments
  115. 7.20 Thermo Fisher Scientific
  116. 7.20.1 Thermo Fisher Scientific Company Information
  117. 7.20.2 Thermo Fisher Scientific Business Overview
  118. 7.20.3 Thermo Fisher Scientific E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Thermo Fisher Scientific E. coli Competent Cells Product Portfolio
  120. 7.20.5 Thermo Fisher Scientific Recent Developments
  121. 7.21 TIANGEN
  122. 7.21.1 TIANGEN Company Information
  123. 7.21.2 TIANGEN Business Overview
  124. 7.21.3 TIANGEN E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 TIANGEN E. coli Competent Cells Product Portfolio
  126. 7.21.5 TIANGEN Recent Developments
  127. 7.22 NCM Biotech
  128. 7.22.1 NCM Biotech Company Information
  129. 7.22.2 NCM Biotech Business Overview
  130. 7.22.3 NCM Biotech E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 NCM Biotech E. coli Competent Cells Product Portfolio
  132. 7.22.5 NCM Biotech Recent Developments
  133. 7.23 Yeasen
  134. 7.23.1 Yeasen Company Information
  135. 7.23.2 Yeasen Business Overview
  136. 7.23.3 Yeasen E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Yeasen E. coli Competent Cells Product Portfolio
  138. 7.23.5 Yeasen Recent Developments
  139. 7.24 ZOMANBIO
  140. 7.24.1 ZOMANBIO Company Information
  141. 7.24.2 ZOMANBIO Business Overview
  142. 7.24.3 ZOMANBIO E. coli Competent Cells Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 ZOMANBIO E. coli Competent Cells Product Portfolio
  144. 7.24.5 ZOMANBIO Recent Developments
8 North America
  1. 8.1 North America E. coli Competent Cells Market Size by Type
  2. 8.1.1 North America E. coli Competent Cells Revenue by Type (2021-2032)
  3. 8.1.2 North America E. coli Competent Cells Sales by Type (2021-2032)
  4. 8.1.3 North America E. coli Competent Cells Price by Type (2021-2032)
  5. 8.2 North America E. coli Competent Cells Market Size by Application
  6. 8.2.1 North America E. coli Competent Cells Revenue by Application (2021-2032)
  7. 8.2.2 North America E. coli Competent Cells Sales by Application (2021-2032)
  8. 8.2.3 North America E. coli Competent Cells Price by Application (2021-2032)
  9. 8.3 North America E. coli Competent Cells Market Size by Country
  10. 8.3.1 North America E. coli Competent Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America E. coli Competent Cells Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America E. coli Competent Cells Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe E. coli Competent Cells Market Size by Type
  2. 9.1.1 Europe E. coli Competent Cells Revenue by Type (2021-2032)
  3. 9.1.2 Europe E. coli Competent Cells Sales by Type (2021-2032)
  4. 9.1.3 Europe E. coli Competent Cells Price by Type (2021-2032)
  5. 9.2 Europe E. coli Competent Cells Market Size by Application
  6. 9.2.1 Europe E. coli Competent Cells Revenue by Application (2021-2032)
  7. 9.2.2 Europe E. coli Competent Cells Sales by Application (2021-2032)
  8. 9.2.3 Europe E. coli Competent Cells Price by Application (2021-2032)
  9. 9.3 Europe E. coli Competent Cells Market Size by Country
  10. 9.3.1 Europe E. coli Competent Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe E. coli Competent Cells Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe E. coli Competent Cells Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China E. coli Competent Cells Market Size by Type
  2. 10.1.1 China E. coli Competent Cells Revenue by Type (2021-2032)
  3. 10.1.2 China E. coli Competent Cells Sales by Type (2021-2032)
  4. 10.1.3 China E. coli Competent Cells Price by Type (2021-2032)
  5. 10.2 China E. coli Competent Cells Market Size by Application
  6. 10.2.1 China E. coli Competent Cells Revenue by Application (2021-2032)
  7. 10.2.2 China E. coli Competent Cells Sales by Application (2021-2032)
  8. 10.2.3 China E. coli Competent Cells Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia E. coli Competent Cells Market Size by Type
  2. 11.1.1 Asia E. coli Competent Cells Revenue by Type (2021-2032)
  3. 11.1.2 Asia E. coli Competent Cells Sales by Type (2021-2032)
  4. 11.1.3 Asia E. coli Competent Cells Price by Type (2021-2032)
  5. 11.2 Asia E. coli Competent Cells Market Size by Application
  6. 11.2.1 Asia E. coli Competent Cells Revenue by Application (2021-2032)
  7. 11.2.2 Asia E. coli Competent Cells Sales by Application (2021-2032)
  8. 11.2.3 Asia E. coli Competent Cells Price by Application (2021-2032)
  9. 11.3 Asia E. coli Competent Cells Market Size by Country
  10. 11.3.1 Asia E. coli Competent Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia E. coli Competent Cells Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia E. coli Competent Cells Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA E. coli Competent Cells Market Size by Type
  2. 12.1.1 SAMEA E. coli Competent Cells Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA E. coli Competent Cells Sales by Type (2021-2032)
  4. 12.1.3 SAMEA E. coli Competent Cells Price by Type (2021-2032)
  5. 12.2 SAMEA E. coli Competent Cells Market Size by Application
  6. 12.2.1 SAMEA E. coli Competent Cells Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA E. coli Competent Cells Sales by Application (2021-2032)
  8. 12.2.3 SAMEA E. coli Competent Cells Price by Application (2021-2032)
  9. 12.3 SAMEA E. coli Competent Cells Market Size by Country
  10. 12.3.1 SAMEA E. coli Competent Cells Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA E. coli Competent Cells Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA E. coli Competent Cells Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 E. coli Competent Cells Value Chain Analysis
  2. 13.1.1 E. coli Competent Cells Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 E. coli Competent Cells Production Mode & Process
  6. 13.2 E. coli Competent Cells Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 E. coli Competent Cells Distributors
  9. 13.2.3 E. coli Competent Cells Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst